Bill · H.R. 1142· House(119-HR-1142)
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
- Introduced
- 2/7/2025
- Last activity
- 2/7/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- David Schweikert
- Cosponsors
- None
- Introduced
- In Committee
What this bill would do
This bill seeks to amend the Public Health Service Act. It directs the Secretary of Health and Human Services to establish drug adherence guidelines. The primary goal of these guidelines is to achieve 90 percent adherence for all Medicare part B and D drugs. The Secretary is required to include artificial intelligence and machine learning technologies in these guidelines. Additionally, the guidelines must promote the use of generic and biosimilar drugs to the maximum extent practicable.
Yes· 3 of 6
Would people over 65 be better off under this?+5
The bill establishes guidelines to improve drug adherence for Medicare Part B and D drugs used by seniors.
Would retired people be better off under this?+5
The bill aims to improve drug adherence for those enrolled in Medicare Part B and D.
Does this lower the price of prescription medicines?+4
The bill directs the Secretary to promote the use of generic and biosimilar drugs to the maximum extent practicable.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Medication Adherence: The bill aims for a goal of 90 percent adherence for all Medicare part B and D drugs, which could benefit patients relying on these medications (Section 1712(a)).
-
Use of Technology: The Secretary must incorporate artificial intelligence and machine learning technologies into the new guidelines (Section 1712(b)(1)).
-
Promotion of Affordable Options: The guidelines will promote the use of generic and biosimilar drugs to the maximum extent practicable (Section 1712(b)(2)).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+5Good For Seniors+5Good For Low Income Households+3
- Healthcare
- Reduces Prescription Drug Costs+4Increases Medicare Funding+2
- Education And Technology
- Increases Scientific Research Funding+1
- 2/7/2025
- Referred to the House Committee on Energy and Commerce.
- Introduced in House